Original language | English (US) |
---|---|
Pages (from-to) | 974-976 |
Number of pages | 3 |
Journal | Headache |
Volume | 59 |
Issue number | 7 |
DOIs | |
State | Published - Jul 1 2019 |
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Migraine Progression : A Systematic Review. An Editorial Comment. / Buse, Dawn C.; Greisman, Jacob D.; Baigi, Khosrow et al.
In: Headache, Vol. 59, No. 7, 01.07.2019, p. 974-976.Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - Migraine Progression
T2 - A Systematic Review. An Editorial Comment
AU - Buse, Dawn C.
AU - Greisman, Jacob D.
AU - Baigi, Khosrow
AU - Lipton, Richard B.
N1 - Funding Information: Disclosures: Dawn C. Buse, PhD, in the past 12 months, has received grant support and honoraria from Allergan, Amgen, Avanir, Biohaven, Eli Lilly, Promeius, and Teva. She is on the editorial board of Current Pain and Headache Reports. Jacob D. Greisman, BA has nothing to disclose. Khosrow Baigi, MD, MPH has nothing to disclose. Richard B. Lipton, MD is the Edwin S. Lowe Professor of Neurology at the Albert Einstein College of Medicine in New York. He receives research support from the NIH: 2PO1 AG003949 (Program Director), 5U10 NS077308 (PI), 1RO1 AG042595 (Investigator), RO1 NS082432 (Investigator), K23 NS09610 (Mentor), K23AG049466 (Mentor). He also receives support from the Migraine Research Foundation and the National Headache Foundation. He serves on the editorial board of Neurology and as senior advisor to Headache. He has reviewed for the NIA and NINDS, holds stock options in eNeura Therapeutics and Biohaven Holdings; serves as consultant, advisory board member, or has received honoraria from: American Academy of Neurology, Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Biohaven, Biovision, Boston Scientific, Colucid, Dr. Reddy’s, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKlein, Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, Vedanta. He receives royalties from Wolff’s Headache, 8th Edition, Oxford Press University, 2009, Wiley and Informa.
PY - 2019/7/1
Y1 - 2019/7/1
UR - http://www.scopus.com/inward/record.url?scp=85068965011&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068965011&partnerID=8YFLogxK
U2 - 10.1111/head.13573
DO - 10.1111/head.13573
M3 - Editorial
C2 - 31297806
AN - SCOPUS:85068965011
SN - 0017-8748
VL - 59
SP - 974
EP - 976
JO - Headache
JF - Headache
IS - 7
ER -